Regulation - Regulation, Nephrology and Hepatology, Velphoro

Vifor’s Velphoro gains marketing authorization in the EU for hyperphosphatemia

Vifor’s Velphoro gains marketing authorization in the EU for hyperphosphatemia

27-08-2014

Switzerland-based iron deficiency specialist Vifor has received European Union marketing authorization…

Chronic kidney diseaseHyperphosphatemiaMedicineNephrologyNephrology and HepatologyPeritoneal dialysisPharmaceuticalRegulationRenal dialysisSwitzerlandVelphoroVifor Pharma

Velphoro receives US FDA approval for hyperphosphatemia in CKD

Velphoro receives US FDA approval for hyperphosphatemia in CKD

28-11-2013

Switzerland-based Vifor Pharma has received US Food and Drug Administration approval for Velphoro for…

Nephrology and HepatologyPharmaceuticalRegulationUSAVelphoroVifor Pharma

Back to top